Unity Biotechnology Inc (UBX) - News Archive

South San Francisco, Calif. - January 7, 2025 - UNITY Biotechnology, Inc. NASDAQ: UBX, a pioneering force in therapeutic development aimed at combating diseases of aging, has announced a strategic leadership enhancement...

SOUTH SAN FRANCISCO, Calif., July 24, 2024 - UNITY Biotechnology, Inc. (UNITY) NASDAQ: UBX, a pioneering biotechnology company renowned for its efforts in developing therapeutics to slow, halt, or reverse diseases assoc...

UNITY Biotechnology Extends Phase 2b ASPIRE Clinical Study for UBX1325 in DME, Aiming to Enhance Durability and Statistical PowerSOUTH SAN FRANCISCO, Calif., April 23, 2024 - UNITY Biotechnology, Inc. (UNITY) NASDAQ: UB...

In the ever-evolving world of biopharmaceuticals, breakthrough achievements occasionally redefine our understanding of disease treatment and management. Such a groundbreaking event recently took place at UNITY Biotechno...

UNITY Biotechnology has marked a significant stride in its ambitious endeavor to combat vision impairment. The company, renowned for developing therapeutics that potentially halt, slow, or reverse age-associated disease...